Skip to main content


  • Brief Report
  • Open Access

Spontaneous splenic infarction associated with sumatriptan use

The Journal of Headache and Pain20067:291

  • Received: 16 April 2006
  • Accepted: 18 May 2006
  • Published:


Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.

Key words

  • Triptan
  • Spleen
  • Infarction


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.